Quest Diagnostics (NYSE:DGX) has been named to the Fortune 2026 World’s Most Admired Companies list, ranking…
Continue ReadingTag: Diagnostics
Guardant Health (NASDAQ:GH): Strongest Q3 Results from the Testing & Diagnostics Services Group
Earnings results often indicate what direction a company will take in the months ahead. With Q3…
Continue Reading
Guardant Health Announces Multi-Year Strategic Collaboration Agreement with Merck to Develop Companion Diagnostics and Commercialize New Cancer Therapies Using Guardant Infinity Smart Platform
Multi-year global collaboration will utilize Guardant liquid biopsy portfolio for the development of companion diagnostics for…
Continue ReadingIs Quest Diagnostics (DGX) Using At-Home STI Tests to Redefine Its Consumer Health Strategy?
In November 2025, Visby Medical announced that Quest Diagnostics’ consumer platform, questhealth.com, added the FDA-authorized at-home…
Continue ReadingStrongest Q3 Results from the Testing & Diagnostics Services Group
Earnings results often indicate what direction a company will take in the months ahead. With Q3…
Continue Reading